Donald Tyler Mappin, RN Registered Nurse Medicare: Medicare Enrolled Practice Location: 4502 Medical Dr, San Antonio, TX 78229 Phone: 210-358-4000 |
Alexandra Angela Brenner, RN Registered Nurse - Emergency Medicare: Not Enrolled in Medicare Practice Location: 13406 Bristow Dawn, San Antonio, TX 78217 Phone: 210-683-3991 |
Joseph E Valdez, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 8610 N New Braunfels Ave Ste 405, San Antonio, TX 78217 Phone: 210-804-0193 |
Ms. Laura A Ramos, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8700 Crownhill Blvd Ste 300, San Antonio, TX 78209 Phone: 210-824-5530 Fax: 210-824-5323 |
Ms. Tammie La Nell Young, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 5726 W Hausman Rd, San Antonio, TX 78249 Phone: 210-349-7030 Fax: 210-349-0097 |
Victor Camilo, RN Registered Nurse - Administrator Medicare: Not Enrolled in Medicare Practice Location: 2735 Nacogdoches Rd, San Antonio, TX 78217 Phone: 210-225-1115 Fax: 210-225-1114 |
Celestina Tengu Ngang, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 5600 Babcock Rd, San Antonio, TX 78240 Phone: 310-462-2847 |
Comfort Akindoju, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7710 W Interstate 10, San Antonio, TX 78230 Phone: 210-377-3355 |
Amanda Victoria De Leon, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10224 Round Rdg, San Antonio, TX 78254 Phone: 210-835-6403 |
Mary Gadison, Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 2700 Ne Loop 410 Ste 101, San Antonio, TX 78217 Phone: 102-832-5081 |
Kristan Victoria Gallegos, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 84 Ne Loop 410, San Antonio, TX 78216 Phone: 210-439-7756 |
Grace Otuokere, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Babcock Rd Ste 304, San Antonio, TX 78229 Phone: 210-731-9570 |
Ruth Olusola Falomo, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 7710 W Interstate 10, San Antonio, TX 78230 Phone: 210-377-3355 |
Marion D Samura, RN Registered Nurse - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8610 N New Braunfels Ave Ste 405, San Antonio, TX 78217 Phone: 210-804-0193 |
Grace Segura, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2515 Castroville Rd, San Antonio, TX 78237 Phone: 210-433-0366 |
Ms. Maricar C Galunza, RN Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 7710 W Interstate 10, San Antonio, TX 78230 Phone: 210-377-3355 |
Jesus Vasquez, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 8700 Crownhill Blvd Ste 300, San Antonio, TX 78209 Phone: 210-824-5530 |
Norma Ashley Cortez, Registered Nurse - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8610 N New Braunfels Ave Ste 405, San Antonio, TX 78217 Phone: 210-804-0193 |
Angel Tyler, NP Registered Nurse Medicare: Medicare Enrolled Practice Location: 13035 Nacogdoches Rd Ste 2, San Antonio, TX 78217 Phone: 210-333-8895 |
Carlos Palmero, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 7710 W Interstate 10, San Antonio, TX 78230 Phone: 210-377-3355 |
News Archive
A new study suggests that women with endometrial cancer should be screened for inherited mutations that could lead to a high risk of several other cancers.
Wyeth Pharmaceuticals, a division of Wyeth, announces findings from a placebo-controlled Phase 3 study of bazedoxifene 20 mg extended to five years, which indicated a significant reduction versus placebo in new vertebral fractures in postmenopausal women with osteoporosis.
A new drug called avosentan significantly lowers urinary protein excretion-an important marker of kidney disease progression-in patients with diabetic kidney disease, according to an international clinical trial appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
A team of scientists from Japan has identified the approved anti-material drug, mefloquine, as a potential candidate to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Specifically, mefloquine has been shown to prevent the entry of SARS-CoV-2 into host cells and reduce the viral load in vitro.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the second quarter of 2010. For the quarter ended June 30, 2010, Orexigen reported a net loss of $11.9 million, or $0.25 per share attributable to common stockholders, as compared to a net loss of $17.8 million, or $0.51 per share attributable to common stockholders, for the second quarter of 2009.
› Verified 2 days ago